![]() |
市場調查報告書
商品編碼
2149585
區塊鏈在醫療記錄和供應鏈完整性領域的市場:2034 年預測——按組件、區塊鏈類型、部署模型、應用、最終用戶和地區分類的全球分析Blockchain for Medical Records & Supply Chain Integrity Market Forecasts to 2034 - Global Analysis By Component (Platforms and Services), Blockchain Type, Deployment Model, Application, End User and By Geography |
||||||
根據 Stratistics MRC 的數據,用於確保醫療記錄和供應鏈完整性的全球區塊鏈市場預計將在 2026 年達到 83 億美元,在預測期內以 50.4% 的複合年成長率成長,到 2034 年達到 2,166 億美元。
區塊鏈技術利用分散式帳本技術來保障醫療記錄和供應鏈的完整性,進而保護醫療資料並提高醫療產品分銷的透明度。這使得醫療機構能夠維護可靠的數位記錄、管理資訊存取權限並減少資料篡改等詐欺行為。在供應鏈中,區塊鏈有助於追蹤藥品和醫療設備、檢驗產品來源、監控交易以及識別仿冒品。這些功能提高了資訊的可靠性,加強了相關人員之間的協作,並促進了整個醫療運作過程中的可追溯性、安全性和課責。
根據美國衛生資訊科技協調辦公室 (ONC) 的數據,到 2023 年,美國 70% 的非聯邦急性護理醫院將經常或偶爾使用電子健康資訊交流的所有四個方面:發送、搜尋、接收和整合資訊。
對安全且可互通的醫療資料管理的需求日益成長。
對安全可靠且易於存取的醫療資訊日益成長的需求,正推動著區塊鏈技術在醫療保健系統中的應用。醫院和其他醫療機構管理著高度敏感的病患記錄,這些記錄需要強大的安全保障和可靠的資訊共用機制。區塊鏈提供去中心化儲存、加密交易以及難以篡改的記錄。這些特性增強了數據的可靠性,同時支援醫療服務提供者、診斷實驗室、保險公司和其他相關人員之間的安全通訊,從而提升了人們對基於區塊鏈的醫療記錄管理平台的興趣。
實施成本高昂,且與現有醫療保健基礎設施的整合複雜
實施區塊鏈並確保其與現有醫療基礎設施相容所需的大量投資限制了市場擴張。許多醫院和醫療機構依賴現有的數位化系統,而整合區塊鏈可能需要進行大規模升級。平台開發、網路安全、基礎設施維護和員工培訓等相關成本可能構成沉重的財務負擔。小規模的醫療機構可能難以分配足夠的資源進行實施。此外,將區塊鏈應用與電子健康記錄和供應鏈平台整合涉及複雜的技術,這可能會減緩醫療機構對區塊鏈的接受度。
區塊鏈、人工智慧和醫療數據整合
將區塊鏈技術與人工智慧和醫學分析相結合,為數位化醫療管理創造了新的成長機會。區塊鏈提供安全檢驗的資訊記錄,而人工智慧則處理醫療數據,產生有價值的見解,並改善營運決策。這些技術的整合可以支援先進的醫療資訊系統、安全的資料共用以及更有效率的醫療管理。人們對智慧醫療平台的日益關注,可能促使技術開發商和醫療機構採用整合解決方案,從而提高資訊的可靠性並支援數據驅動的醫療服務。
區塊鏈網路的網路安全漏洞和潛在攻擊
網路攻擊和安全漏洞的潛在風險對區塊鏈在醫療資訊系統和供應鏈系統中的應用構成挑戰。儘管分散式帳本能夠保護已記錄的交易,但相關的軟體、使用者憑證、連網設備和網路元件仍然容易受到安全風險的影響。存取金鑰被盜、智慧合約有缺陷以及惡意系統活動都可能導致敏感醫療記錄外洩或產品追蹤中斷。這些威脅會削弱公眾對醫療機構的信任,增加營運成本,並促使醫療機構投資建立更強大的網路安全基礎設施和進行定期系統評估。
新冠疫情凸顯了保護可靠醫療數據和高效監控供應鏈的必要性,也引發了人們對區塊鏈在醫療保健領域應用的濃厚興趣。疫苗、藥品和醫療設備需求的激增暴露了分銷網路和產品追蹤方面的漏洞。醫療服務提供者和供應鏈相關人員對能夠支援安全資訊交流和產品真偽驗證的數位化解決方案表現出更大的興趣。因此,區塊鏈作為一種能夠改善醫療記錄管理、藥品溯源、分銷透明度和醫療緊急情況下協作的技術,受到了廣泛關注。
在預測期內,基於雲端的細分市場預計將佔據最大的市場佔有率。
由於其易於部署、營運柔軟性且能夠滿足不斷成長的醫療保健需求,預計在預測期內,基於雲端的區塊鏈技術將佔據最大的市場佔有率。這些平台使醫療機構無需對實體基礎設施進行大量投資即可維護和共用區塊鏈保護的資訊。醫院、製藥公司、供應商和醫療保健專業人員可以透過網路存取相關記錄。此外,由於其易於維護、可遠端存取且與數位醫療應用程式相容,基於雲端的區塊鏈技術非常適合改善醫療保健資訊管理並提高藥品供應鏈的透明度。
在預測期內,製藥公司板塊預計將呈現最高的複合年成長率。
在預測期內,隨著製造商對可靠的藥品追蹤和真偽驗證系統的需求日益成長,製藥公司預計將呈現最高的成長率。區塊鏈技術能夠幫助製藥公司在生產、倉儲、運輸和分銷等各個環節維護檢驗的產品記錄。這提高了產品流轉的透明度,支持藥品真偽驗證,並增強了交易記錄的可靠性。對預防假藥、監管要求和安全藥品分銷的日益關注,促使製造商將區塊鏈平台整合到其營運中,為整個藥品供應鏈更廣泛地應用區塊鏈技術創造了機會。
在預測期內,北美預計將佔據最大的市場佔有率,這得益於其完善的醫療保健基礎設施和廣泛應用的數位化醫療解決方案。該地區受益於眾多製藥企業、科技公司和醫療機構對區塊鏈應用的探索。在美國,為促進藥品安全追蹤和產品檢驗而採取的監管措施正在推動基於區塊鏈的解決方案的發展。此外,人們對保護病患資訊、醫療保健互通性和透明藥品分銷的日益關注也促進了區塊鏈在北美地區的普及應用。
在預測期內,亞太地區預計將呈現最高的複合年成長率,這主要得益於不斷擴大的數位醫療基礎設施、藥品生產和技術投資。中國、印度、日本和韓國等國家正大力發展先進的醫療資訊系統和數位供應鏈能力。保護病患資訊、確保藥品真偽以及改進藥品追蹤系統的需求日益成長,推動了人們對區塊鏈應用的興趣。此外,政府主導的醫療現代化計畫和技術創新的進步也促使各機構考慮實施基於區塊鏈的醫療記錄和供應鏈解決方案。
According to Stratistics MRC, the Global Blockchain for Medical Records & Supply Chain Integrity Market is accounted for $8.3 billion in 2026 and is expected to reach $216.6 billion by 2034 growing at a CAGR of 50.4% during the forecast period. Blockchain for Medical Records & Supply Chain Integrity involves applying distributed ledger technology to protect healthcare data and enhance transparency in medical product distribution. It allows healthcare providers to maintain reliable digital records, control information access, and reduce unauthorized data alterations. Within supply chains, blockchain supports tracking medicines and medical equipment, validating product origins, monitoring transactions, and identifying potential counterfeit products. These capabilities improve information reliability, strengthen coordination among stakeholders, and promote greater traceability, security, and accountability throughout healthcare operations.
According to the U.S. Office of the National Coordinator for Health Information Technology (ONC), 70% of non-federal acute care hospitals in the United States engaged in all four domains of electronic health information exchange (sending, finding, receiving, and integrating information) either routinely or sometimes in 2023.
Increasing demand for secure and interoperable healthcare data management
Rising demand for protected and accessible medical information is supporting the adoption of blockchain across healthcare systems. Hospitals and other medical institutions manage confidential patient records that require strong security and dependable information-sharing mechanisms. Blockchain offers distributed storage, encrypted transactions, and records that are difficult to alter without authorization. These capabilities help improve data reliability while supporting secure communication between healthcare providers, diagnostic laboratories, insurance companies, and other stakeholders, increasing interest in blockchain-enabled medical record management platforms.
High implementation costs and complex integration with existing healthcare
The significant investment required for blockchain deployment and compatibility with existing healthcare infrastructure limits market expansion. Many hospitals and medical institutions rely on established digital systems that may require considerable upgrades before blockchain integration. Expenses associated with platform development, cybersecurity, infrastructure maintenance, and workforce training can create financial pressure. Smaller healthcare facilities may struggle to allocate sufficient resources for adoption. Furthermore, connecting blockchain applications with electronic medical records and supply chain platforms involves technical complexities that can delay implementation across healthcare organizations.
Integration of blockchain with artificial intelligence and healthcare data
Combining blockchain technology with artificial intelligence and healthcare analytics creates new growth opportunities in digital healthcare management. Blockchain offers protected and verifiable information records, while artificial intelligence helps process medical data to generate useful insights and improve operational decisions. Their integration can support advanced medical information systems, secure data sharing, and more efficient healthcare administration. Increasing interest in intelligent healthcare platforms may encourage technology developers and medical institutions to introduce integrated solutions that strengthen information reliability and support data-based healthcare services.
Cybersecurity vulnerabilities and potential blockchain network attacks
The possibility of cyberattacks and security weaknesses presents challenges for blockchain adoption across healthcare information and supply chain systems. While distributed ledgers protect recorded transactions, associated software, user credentials, connected devices, and network components can still face security risks. Stolen access keys, defective smart contracts, and unauthorized system activities may expose confidential medical records or disrupt product tracking. These threats can affect organizational trust, increase operational expenses, and encourage healthcare institutions to invest in stronger cybersecurity infrastructure and regular system assessments.
The COVID-19 outbreak increased attention toward blockchain applications in healthcare by demonstrating the need for reliable medical data protection and efficient supply chain monitoring. Rising requirements for vaccines, pharmaceutical products, and medical equipment exposed weaknesses in distribution networks and product tracking. Healthcare providers and supply chain participants showed greater interest in digital solutions that support secure information exchange and product authentication. Consequently, blockchain gained attention as a technology for improving medical record management, pharmaceutical traceability, distribution transparency, and coordination during healthcare emergencies.
The cloud-based segment is expected to be the largest during the forecast period
The cloud-based segment is expected to account for the largest market share during the forecast period due to their convenient deployment, operational flexibility, and ability to support expanding healthcare requirements. These platforms enable medical institutions to maintain and share blockchain-protected information without investing heavily in physical infrastructure. Hospitals, drug manufacturers, suppliers, and healthcare professionals can access relevant records across connected networks. Additionally, easier system maintenance, remote accessibility, and compatibility with digital healthcare applications make cloud-based blockchain technology suitable for improving medical information management and pharmaceutical supply chain transparency.
The pharmaceutical companies segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the pharmaceutical companies segment is predicted to witness the highest growth rate as manufacturers increasingly require reliable medicine tracking and authentication systems. Blockchain technology helps pharmaceutical businesses maintain verifiable product records across manufacturing, warehousing, transportation, and distribution activities. It improves visibility into product movements, supports medicine authenticity checks, and strengthens transaction documentation. Increasing attention toward counterfeit drug prevention, regulatory requirements, and secure pharmaceutical distribution is encouraging manufacturers to integrate blockchain platforms into their operations, creating opportunities for wider adoption across pharmaceutical supply chains.
During the forecast period, the North America region is expected to hold the largest market share, supported by developed medical infrastructure and widespread adoption of digital healthcare solutions. The region benefits from the presence of pharmaceutical manufacturers, technology companies, and healthcare institutions exploring blockchain applications. In the United States, regulatory initiatives promoting secure pharmaceutical tracking and product verification encourage the development of blockchain-based solutions. Additionally, increasing attention toward patient information protection, healthcare interoperability, and transparent medicine distribution contributes to the expansion of blockchain applications throughout North America.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, supported by expanding digital healthcare infrastructure, pharmaceutical production, and technology investments. Countries including China, India, Japan, and South Korea are increasingly developing advanced healthcare information systems and digital supply chain capabilities. The need for protected patient information, reliable medicine verification, and improved pharmaceutical tracking is creating interest in blockchain applications. Additionally, government-backed healthcare modernization programs and growing technology innovation are encouraging organizations to explore blockchain-based medical record and supply chain solutions.
Key players in the market
Some of the key players in Blockchain for Medical Records & Supply Chain Integrity Market include IBM Corporation, Microsoft Corporation, Oracle Corporation, Guardtime, Patientory Inc., Medicalchain, BurstIQ, Chronicled Inc., Hashed Health, Avaneer Health, Embleema Inc., Blockpharma, Solve.Care, SimplyVital Health, Coral Health, FarmaTrust, MediBloc Inc. and EncrypGen Inc.
In June 2026, Oracle Health and Theator are working together to provide AI-powered surgical intelligence solutions to Oracle Health customers in the U.S. With Theator's solutions, which capture surgical video footage and use AI to analyze it and cross-reference EHR data, surgical teams can benefit from automated reporting that is more clinically accurate, optimized for billing, and tailored to individual preferences, with no transcription or dictation required.
In December 2025, IBM and Confluent, Inc. announced they have entered into a definitive agreement under which IBM will acquire all of the issued and outstanding common shares of Confluent for $31 per share, representing an enterprise value of $11 billion. Confluent provides a leading open-source enterprise data streaming platform that connects processes and governs reusable and reliable data and events in real time, foundational for the deployment of AI.
In October 2025, Microsoft Corp. on unveiled AI innovations, leveraging ambient and generative technologies, to improve the patient journey, reduce the workflow burden across care teams and enhance the financial integrity of healthcare provider organizations. Microsoft is expanding the capabilities of its leading AI clinical assistant, Dragon Copilot, by introducing the first commercially available ambient experience created for nursing workflows and new extensibility capabilities that allow partners to unlock additional value for Dragon Copilot users.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.